Lexaria Bioscience (LEXX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $2.99, +6.03% vs the prior close of $2.82.
- Volume 37.20K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
LEXX jumps 6.0% to $2.99. Closed at $2.99, +6.03% vs the prior close of $2.82. Day range $2.74–$3.11, opened at $2.74.
LEXX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — LEXX jumps 6.0% to $2.99
- Closed at $2.99, +6.03% vs the prior close of $2.82. Day range $2.74–$3.11, opened at $2.74.
- Volume was 37.20K shares, 0.4x its 50-day average of 83.87K — lighter than usual.
- Price is -53.2% vs its 50-day average ($6.39) and -68.1% vs its 200-day average ($9.37).
- 52-week range $2.43–$21.60; today's close sits at 3% of that range, 86.2% below the 52-week high.
Oct 14, 2026 — LEXX rises 0.7% to $2.82
- Closed at $2.82, +0.71% vs the prior close of $2.80. Day range $2.43–$2.92, opened at $2.81.
- Volume was 103.90K shares, 1.2x its 50-day average of 83.16K.
- Price is -56.2% vs its 50-day average ($6.45) and -70.0% vs its 200-day average ($9.39).
- 52-week range $2.43–$21.60; today's close sits at 2% of that range, 86.9% below the 52-week high.
Oct 13, 2026 — LEXX slides 14.4% to $2.80
- Closed at $2.80, -14.37% vs the prior close of $3.27. Day range $2.69–$3.29, opened at $3.29.
- Volume was 117.90K shares, 1.4x its 50-day average of 82.03K.
- Price is -56.9% vs its 50-day average ($6.50) and -70.3% vs its 200-day average ($9.42).
- 52-week range $2.69–$21.60; today's close sits at 1% of that range, 87.0% below the 52-week high.
Oct 12, 2026 — LEXX dips 1.5% to $3.27
- Closed at $3.27, -1.51% vs the prior close of $3.32. Day range $3.18–$3.62, opened at $3.18.
- Volume was 66.10K shares, 0.8x its 50-day average of 81.36K.
- Price is -50.0% vs its 50-day average ($6.54) and -65.4% vs its 200-day average ($9.45).
- 52-week range $2.77–$21.60; today's close sits at 3% of that range, 84.9% below the 52-week high.
Oct 9, 2026 — LEXX jumps 3.7% to $3.32 on 2.5x normal volume
- Closed at $3.32, +3.75% vs the prior close of $3.20. Day range $3.12–$3.90, opened at $3.31.
- Volume was 198.40K shares, 2.5x its 50-day average of 78.36K — unusually heavy trading.
- Price is -49.6% vs its 50-day average ($6.59) and -65.0% vs its 200-day average ($9.48).
- 52-week range $2.77–$21.60; today's close sits at 3% of that range, 84.6% below the 52-week high.
Oct 8, 2026 — LEXX slides 7.5% to $3.20
- Closed at $3.20, -7.51% vs the prior close of $3.46. Day range $3.19–$3.67, opened at $3.50.
- Volume was 26.50K shares, 0.3x its 50-day average of 77.93K — lighter than usual.
- Price is -51.8% vs its 50-day average ($6.64) and -66.4% vs its 200-day average ($9.51).
- 52-week range $2.77–$21.60; today's close sits at 2% of that range, 85.2% below the 52-week high.
Oct 7, 2026 — LEXX jumps 6.8% to $3.46
- Closed at $3.46, +6.79% vs the prior close of $3.24. Day range $3.10–$3.59, opened at $3.14.
- Volume was 76.90K shares, 1.0x its 50-day average of 76.46K.
- Price is -48.7% vs its 50-day average ($6.74) and -63.7% vs its 200-day average ($9.54).
- 52-week range $2.77–$21.60; today's close sits at 4% of that range, 84.0% below the 52-week high.
Oct 6, 2026 — LEXX jumps 17.0% to $3.24
- Closed at $3.24, +16.97% vs the prior close of $2.77. Day range $2.86–$3.24, opened at $2.92.
- Volume was 66.10K shares, 0.9x its 50-day average of 75.28K.
- Price is -52.6% vs its 50-day average ($6.83) and -66.2% vs its 200-day average ($9.57).
- 52-week range $2.77–$21.60; today's close sits at 2% of that range, 85.0% below the 52-week high.
Oct 5, 2026 — LEXX slides 3.8% to $2.77, a 52-week low, 3 down days in a row
- Closed at $2.77, -3.82% vs the prior close of $2.88. Day range $2.77–$3.12, opened at $2.90.
- Volume was 38.70K shares, 0.5x its 50-day average of 74.52K — lighter than usual.
- Price is -60.0% vs its 50-day average ($6.92) and -71.2% vs its 200-day average ($9.61).
- 52-week range $2.77–$21.60; today's close sits at 0% of that range, 87.2% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — LEXX slides 6.8% to $2.88, a 52-week low
- Closed at $2.88, -6.80% vs the prior close of $3.09. Day range $2.80–$3.24, opened at $3.18.
- Volume was 80.10K shares, 1.1x its 50-day average of 72.97K.
- Price is -59.1% vs its 50-day average ($7.04) and -70.2% vs its 200-day average ($9.66).
- 52-week range $2.80–$21.60; today's close sits at 0% of that range, 86.7% below the 52-week high.
- SEC filings that day: S-3.
LEXX latest news & SEC filings
Every SEC filing by or about LEXX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Oct 13, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 2, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Jul 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Jul 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended May 31, 2026:
- Revenue: $0 (prior year $174.00K) (-100.0% vs May 31, 2025)
- Net income: -$1.99M (prior year -$3.79M) (loss narrowed vs May 31, 2025)
- Diluted EPS: -$0.08 (prior year -$0.21) (loss narrowed vs May 31, 2025)
Things to know before you trade LEXX
- How much it moves: over the last 20 sessions the average daily move was 4.80% (largest 17.0%). That is a volatile stock.
- Liquidity: about 65.65K shares (≈$196.29K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.99 vs a range of $2.43–$21.60 (3% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:15 on Aug 3, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 9, 2026; 8-K Sep 1, 2026; 8-K Aug 17, 2026.
- Share count: 24.79M shares outstanding (Jul 13, 2026), +26.7% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
LEXX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 2.74 | 3.11 | 2.74 | 2.99 | 37.20K |
| Oct 14, 2026 | 2.81 | 2.92 | 2.43 | 2.82 | 103.90K |
| Oct 13, 2026 | 3.29 | 3.29 | 2.69 | 2.80 | 117.90K |
| Oct 12, 2026 | 3.18 | 3.62 | 3.18 | 3.27 | 66.10K |
| Oct 9, 2026 | 3.31 | 3.90 | 3.12 | 3.32 | 198.40K |
| Oct 8, 2026 | 3.50 | 3.67 | 3.19 | 3.20 | 26.50K |
| Oct 7, 2026 | 3.14 | 3.59 | 3.10 | 3.46 | 76.90K |
| Oct 6, 2026 | 2.92 | 3.24 | 2.86 | 3.24 | 66.10K |
| Oct 5, 2026 | 2.90 | 3.12 | 2.77 | 2.77 | 38.70K |
| Oct 2, 2026 | 3.18 | 3.24 | 2.80 | 2.88 | 80.10K |
| Oct 1, 2026 | 3.20 | 3.25 | 2.95 | 3.09 | 48.70K |
| Sep 30, 2026 | 3.21 | 3.29 | 3.06 | 3.15 | 23.10K |
| Sep 29, 2026 | 3.28 | 3.34 | 2.98 | 3.13 | 77.50K |
| Sep 28, 2026 | 3.25 | 3.46 | 3.15 | 3.22 | 41.90K |
| Sep 25, 2026 | 3.45 | 3.45 | 3.15 | 3.28 | 34.20K |
| Sep 24, 2026 | 3.29 | 3.60 | 3.14 | 3.37 | 51.80K |
| Sep 23, 2026 | 3.31 | 3.34 | 3.10 | 3.23 | 14.40K |
| Sep 22, 2026 | 3.54 | 3.84 | 3.08 | 3.22 | 107.30K |
| Sep 21, 2026 | 3.29 | 3.48 | 3.15 | 3.42 | 26.00K |
| Sep 18, 2026 | 3.25 | 3.52 | 3.15 | 3.24 | 76.30K |
About Lexaria Bioscience
Lexaria Bioscience (LEXX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in KELOWNA, British Columbia, Canada. State of incorporation: NV. Fiscal year ends August 31. SEC CIK 1348362.
LEXX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Christopher Bunka | Director | Mar 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
LEXX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Aug 31, 2025 | — | $-11.90M | -0.66 | $-10.45M |
| Aug 31, 2024 | $464.28K | $-5.80M | -0.47 | $-4.96M |
| Aug 31, 2023 | $226.21K | $-6.66M | -1.01 | $-5.88M |
| Aug 31, 2022 | $255.40K | $-7.27M | — | $-4.88M |
| Aug 31, 2021 | $722.74K | $-4.03M | — | $-3.99M |
Latest balance sheet: total assets $4.78M, total liabilities $437.09K, cash $3.50M (as of May 31, 2026).
LEXX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on LEXX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.